Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
77,331,078
-
Total 13F shares
-
33,294,296
-
Share change
-
+118,652
-
Total reported value
-
$619,929,580
-
Put/Call ratio
-
15%
-
Price per share
-
$18.62
-
Number of holders
-
98
-
Value change
-
+$2,294,891
-
Number of buys
-
40
-
Number of sells
-
31
Institutional Holders of Xenon Pharmaceuticals Inc. - Common Stock (XENE) as of Q2 2021
As of 30 Jun 2021 Xenon Pharmaceuticals Inc. - Common Stock (XENE) had 98 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 33,294,296 shares of stock of the company.
Largest 10 holders included Avoro Capital Advisors LLC, FMR LLC, PERCEPTIVE ADVISORS LLC, BVF INC/IL, ADAGE CAPITAL PARTNERS GP, L.L.C., EVENTIDE ASSET MANAGEMENT, LLC, ORBIMED ADVISORS LLC, Capital International Investors, CITADEL ADVISORS LLC, and NEA Management Company, LLC.
This table shows 98 institutional shareholders of the security as of 30 Jun 2021.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.